|
Exicure, Inc. (XCUR) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Exicure, Inc. (XCUR) Bundle
Vous cherchez à évaluer la valeur intrinsèque d'Exiure, Inc.? Notre calculatrice XCUR DCF intègre des données réelles avec des options de personnalisation complètes, vous permettant d'ajuster les prévisions et d'améliorer vos stratégies d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.3 | 16.6 | -.5 | 28.8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 1181.87 | -102.91 | -6068.12 | -100 | -50 | -50 | -50 | -50 | -50 |
| EBITDA | -24.8 | -22.6 | -60.6 | .1 | -15.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1913.04 | -136.33 | 12553.21 | 0.27059 | 100 | 0.05411781 | 0.05411781 | 0.05411781 | 0.05411781 | 0.05411781 |
| Depreciation | .7 | 1.4 | 1.8 | 1.9 | 1.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 55.86 | 8.71 | -368.32 | 6.44 | 100 | 14.2 | 14.2 | 14.2 | 14.2 | 14.2 |
| EBIT | -25.5 | -24.1 | -62.4 | -1.8 | -16.9 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -1968.9 | -145.04 | 12921.53 | -6.17 | 100 | -1.23 | -1.23 | -1.23 | -1.23 | -1.23 |
| Total Cash | 110.8 | 82.1 | 39.1 | 8.6 | .8 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .3 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 2.7 | 0.06621321 | 0 | 0 | 100 | 20.55 | 20.55 | 20.55 | 20.55 | 20.55 |
| Inventories | .0 | 3.0 | .0 | .5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 18.24 | 0 | 1.77 | 100 | 24 | 24 | 24 | 24 | 24 |
| Accounts Payable | 1.8 | 1.9 | 3.4 | .4 | 1.6 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 139.97 | 11.23 | -706.63 | 1.25 | 100 | 22.5 | 22.5 | 22.5 | 22.5 | 22.5 |
| Capital Expenditure | -1.1 | -3.2 | -1.0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -83.49 | -19.09 | 200.41 | -0.0346909 | 100 | -20.52 | -20.52 | -20.52 | -20.52 | -20.52 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -25.5 | -24.1 | -62.4 | -1.9 | -16.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -24.1 | -28.8 | -57.0 | -3.7 | -14.0 | -1.4 | .0 | .0 | .0 | .0 |
| WACC, % | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 | 20.37 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 6 | |||||||||
| Equity Value | -7 | |||||||||
| Diluted Shares Outstanding, MM | 8 | |||||||||
| Equity Value Per Share | -0.87 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Exicure, Inc.’s (XCUR) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Exicure, Inc. (XCUR).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Exicure, Inc. (XCUR).
- Interactive Dashboard and Charts: Visual representations highlight key valuation metrics for straightforward analysis.
How It Works
- 1. Download the Template: Get the Excel file containing Exicure, Inc.'s (XCUR) preloaded data.
- 2. Adjust Assumptions: Modify essential inputs such as growth rates, WACC, and capital expenditures.
- 3. View Instant Results: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
- 5. Present with Confidence: Deliver professional valuation insights to enhance your decision-making.
Why Choose This Calculator for Exicure, Inc. (XCUR)?
- Accuracy: Utilizes real Exicure financials for precise data representation.
- Flexibility: Tailored for users to easily adjust and experiment with inputs.
- Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected at the CFO level.
- User-Friendly: Intuitive interface suitable for users with varying levels of financial modeling expertise.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to Exicure, Inc. (XCUR).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Exicure, Inc. (XCUR) stock.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech companies like Exicure, Inc. (XCUR) are valued in the financial markets.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Exicure, Inc. (XCUR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), featuring parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models demonstrating intrinsic value with comprehensive calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to facilitate thorough analysis.
- Key Ratios: Incorporates profitability, leverage, and efficiency ratios for Exicure, Inc. (XCUR).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions for easy result analysis.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.